Aurora Spine Corp. announced that it made a private stock offering worth a potential $5 million.
The Carlsbad-Calif.-based medical device company priced shares within the context of the current market, planning to close the offering in January 2014.
Aurora expects to put the earnings towards "manufacturing, sales and marketing of the company’s ZIP & other FDA approved products and for general working capital purposes," according to a press release.
Aurora Spine announced its IPO in late August. The early-stage company issued nearly 5.2 million shares at a per-share price of 70¢. Aurora develops spinal implants, with a focus in minimally invasive, regenerative technologies for patients with degenerative disc disease.